PLAINSBORO, N.J., Oct. 9, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the launch of the Mobius(TM) Multi Modality Monitoring System as the latest addition to Integra’s neuromonitoring product line. The Mobius system has received 510K clearance from the United States Food and Drug Administration (FDA). Integra is featuring the Mobius system at the Congress of Neurological Surgeons Meeting in Chicago this week.
